| Literature DB >> 35356697 |
Houguo Xu1,2, Xing Luo1, Yuliang Wei1,2, Mengqing Liang1,2.
Abstract
Lysophosphatidylcholine (LPC) has been widely used as emulsifier in animal feeds to enhance the lipid utilization. However, the effects of LPC on fillet quality has rarely been known. The present study was the first time to investigate the response of fish muscle lipidomics to dietary LPC supplementation. Turbot muscle samples were collected after a 56-day feeding trial where the experimental diet contained 0 or 0.25% LPC. Targeted tandem mass spectrometry was used in the lipidomic analysis. A total of 62 individual lipids (58 up-regulated and 7 down-regulated by LPC) showed significant difference in concentration in response to dietary LPC. Most of these differentially abundant lipids were diacylglycerol, free fatty acid and cardiolipin, and they all were up-regulated by dietary LPC. However, LPC exerted only marginal effects on muscle fatty acid composition and lipid content. The effects of dietary LPC on fillet lipid composition cannot be neglected in fish product evaluation.Entities:
Keywords: BMP, bis(monoacylglycero)phosphate; CE, cholesteryl ester; CL, cardiolipin; Cer, ceramide; Cho, cholesterol; DAG, diacylglycerol; Dietary regulation; FFA, free fatty acid; GM3, monosialodihexosyl ganglioside; GalCer, galactosylceramide; GluCer, glucosylceramide; LPA, lysophosphatidic acid; LPC, lysophosphatidylcholine; LPE, lysophosphatidylethanolamine; LPI, lysophosphatidylinositol; LPS, lysophosphatidylserine; LacCer, lactosylceramide; Lipidomics; Lysophospholipid; PA, phosphatidic acid; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PG, phosphatidylglycerol; PI, phosphatidylinositol; PS, phosphatidylserine; S1P, sphingosine 1-phosphate; SL, sulfolipid; SM, sphingomyelin; Scophthalmus maximus; Sph, sphingosine; TAG, triacylglycerol
Year: 2022 PMID: 35356697 PMCID: PMC8958321 DOI: 10.1016/j.fochx.2022.100293
Source DB: PubMed Journal: Food Chem X ISSN: 2590-1575
Lipid metabolites having significantly (P < 0.05) different abundance between LPC and the control group. Fold: LPC/control. “↑” and “↓” represents up- and down-regulation by dietary LPC, respectively.
| Lipid | Fold | Lipid | Fold | ||
|---|---|---|---|---|---|
| DAG32:2(16:1/16:1) | 0.0043 | 1.58↑ | PG36:3(16:0_20:3) | 0.0173 | 1.63↑ |
| DAG34:2(16:0/18:2) | 0.0043 | 1.70↑ | CL68:6(16:1) | 0.0173 | 0.62↓ |
| DAG34:1(16:0/18:1) | 0.0043 | 1.46↑ | CL70:5(16:1) | 0.0173 | 0.75↓ |
| DAG36:3(18:2/18:1) | 0.0043 | 1.67↑ | CL78:11(20:3) | 0.0173 | 1.38↑ |
| DAG36:2(18:2/18:0) | 0.0043 | 1.58↑ | FFA20:5 | 0.0173 | 1.60↑ |
| DAG36:1(18:1/18:0) | 0.0043 | 1.74↑ | FFA17:1 | 0.0173 | 1.37↑ |
| DAG38:5(16:1/22:5) | 0.0043 | 1.87↑ | PE38:4 | 0.0173 | 1.27↑ |
| DAG38:4(18:1/20:3) | 0.0043 | 1.66↑ | PA38:6 | 0.0173 | 1.46↑ |
| CL70:7(16:1) | 0.0043 | 0.68↓ | 18:3-carnitine | 0.0173 | 1.87↑ |
| CL70:6(16:1) | 0.0043 | 0.71↓ | 20:4-carnitine | 0.0173 | 2.28↑ |
| CL70:6(18:2) | 0.0043 | 0.73↓ | 20:5-carnitine | 0.0173 | 1.93↑ |
| CL76:9(18:2) | 0.0043 | 1.22↑ | LPC20:5 | 0.0173 | 2.03↑ |
| FFA22:5 | 0.0043 | 1.59↑ | LPC22:6 | 0.0173 | 1.84↑ |
| FFA18:1 | 0.0043 | 1.33↑ | LPC22:5 | 0.0173 | 2.03↑ |
| PE42:0p | 0.0043 | 1.32↑ | DAG32:2(18:2/14:0) | 0.0303 | 1.63↑ |
| DAG34:2(16:1/18:1) | 0.0087 | 1.54↑ | DAG32:1(16:1/16:0) | 0.0303 | 1.41↑ |
| DAG36:2(18:1/18:1) | 0.0087 | 1.55↑ | DAG32:1(14:0/18:1) | 0.0303 | 1.45↑ |
| DAG38:6(16:0/22:6) | 0.0087 | 1.83↑ | DAG32:0(16:0/16:0) | 0.0303 | 1.39↑ |
| DAG38:6(18:1/20:5) | 0.0087 | 1.77↑ | DAG36:4(18:2/18:2) | 0.0303 | 1.72↑ |
| DAG40:6(18:1/22:5) | 0.0087 | 1.60↑ | CL72:9(16:1) | 0.0303 | 0.77↓ |
| CL70:8(16:1) | 0.0087 | 0.70↓ | CL76:10(20:3) | 0.0303 | 1.18↑ |
| CL72:9(18:2) | 0.0087 | 0.83↑ | CL78:13(20:3) | 0.0303 | 1.27↑ |
| CL78:12(20:3) | 0.0087 | 1.38↑ | CL78:12(18:2) | 0.0303 | 1.29↑ |
| CL78:11(18:2) | 0.0087 | 1.35↑ | FFA18:4 | 0.0303 | 1.63↑ |
| FFA22:4 | 0.0087 | 1.42↑ | PI 40:6 | 0.0303 | 1.17↑ |
| FFA20:4 | 0.0087 | 1.51↑ | LPA18:3 | 0.0303 | 1.57↑ |
| FFA18:3 | 0.0087 | 1.73↑ | Cer d18:1/24:0 | 0.0303 | 1.79↑ |
| FFA18:2 | 0.0087 | 1.65↑ | 16:2-carnitine | 0.0303 | 2.04↑ |
| GluCer d18:1/23:0 | 0.0087 | 1.66↑ | LPC18:2 | 0.0303 | 1.65↑ |
| DAG34:3(16:2/18:1) | 0.0173 | 1.53↑ | LPC20:4 | 0.0303 | 1.97↑ |
| DAG34:3(18:2/16:1) | 0.0173 | 1.65↑ | LPA20:5 | 0.0353 | 1.61↑ |
Fig. 1Heatmap of lipid class. The average concentration of a lipid metabolite was standardized to be 0. Higher concentration than the average was labeled as orange, and lower concentration was labeled as purple. The color value as indicated in the right color bar means fold of standard deviation distant to the average concentration. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Fig. 2Heatmap of identified diacylglycerols (DAG). The average concentration of a lipid metabolite was standardized to be 0. Higher concentration than the average was labeled as orange, and lower concentration was labeled as purple. The color value as indicated in the right color bar means fold of standard deviation distant to the average concentration. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Fig. 3Heatmap of identified free fatty acids (FFA). The average concentration of a lipid metabolite was standardized to be 0. Higher concentration than the average was labeled as orange, and lower concentration was labeled as purple. The color value as indicated in the right color bar means fold of standard deviation distant to the average concentration. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Fatty acid composition in the muscle (% total fatty acid).
| Fatty acid | Control | LPC |
|---|---|---|
| C14:0 | 2.06 ± 0.17 | 1.99 ± 0.05 |
| C16:0 | 18.2 ± 0.60 | 18.3 ± 0.29 |
| C16:1n-7 | 2.16 ± 0.16 | 2.06 ± 0.06 |
| C18:0 | 6.09 ± 0.06 | 5.77 ± 0.08 |
| C18:1n-9t | 0.19 ± 0.03 | 0.22 ± 0.02 |
| C18:1n-9c | 18.4 ± 0.38 | 17.7 ± 0.32 |
| C18:2n-6t | 0.13 ± 0.01 | 0.14 ± 0.01 |
| C18:2n-6c | 25.6 ± 0.99 | 25.2 ± 0.39 |
| C20:0 | 0.29 ± 0.02 | 0.26 ± 0.01 |
| C18:3n-6 | 0.10 ± 0.05 | 0.17 ± 0.00 |
| C20:1n-9 | 1.51 ± 0.03a | 1.42 ± 0.02bc |
| C18:3n-3 | 2.14 ± 0.17 | 2.09 ± 0.07 |
| C20:2n-6 | 1.22 ± 0.05 | 1.16 ± 0.02 |
| C22:0 | 0.12 ± 0.00 | 0.09 ± 0.00 |
| C22:1n-9 | 0.26 ± 0.02a | 0.21 ± 0.02b |
| C20:3n-3 | 0.22 ± 0.01 | 0.23 ± 0.00 |
| C20:4n-6 | 1.19 ± 0.08 | 1.23 ± 0.03 |
| C22:2n-6 | 0.08 ± 0.01 | 0.07 ± 0.01 |
| C20:5n-3 | 4.25 ± 0.17 | 4.35 ± 0.13 |
| C24:1n-9 | 0.17 ± 0.01a | 0.13 ± 0.00b |
| C22:6n-3 | 15.2 ± 0.81 | 16.5 ± 0.68 |
Data in the same row not sharing a same superscript letter were significantly different (P < 0.05).
Fig. 4Heatmap of identified cardiolipin (CL). The average concentration of a lipid metabolite was standardized to be 0. Higher concentration than the average was labeled as orange, and lower concentration was labeled as purple. The color value as indicated in the right color bar means fold of standard deviation distant to the average concentration. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)